Teleflex Incorporated has appointed Sean M. Salmon, a veteran medical technology executive, to its Board of Directors, effective September 8, 2026. Salmon brings over three decades of leadership experience, including more than 20 years at Medtronic, where he most recently served as Executive Vice President and President of its Cardiovascular Portfolio, a business with fiscal 2025 revenue of approximately $12.5 billion. He currently serves as an independent director of Adagio Medical Holdings. Following his appointment, one third of the Board has been refreshed in 2026, and the Board now comprises nine directors, eight of whom are independent. Salmon will also serve on the Growth and Operating Committee, which supports the company's strategic transformation.
Teleflex IncorporatedAppointment of experienced director to board supports strategic transformation.
Adagio Medical Holdings, Inc Common Stock
Medtronic PLC